Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37206
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBardin P.G.en
dc.contributor.authorYo S.W.en
dc.contributor.authorRangaswamy J.en
dc.date.accessioned2021-05-14T12:39:00Zen
dc.date.available2021-05-14T12:39:00Zen
dc.date.copyright2018en
dc.date.created20190906en
dc.date.issued2019-09-06en
dc.identifier.citationMedical Journal of Australia. 209 (2 Supplement) (pp S11-S17.e3), 2018. Date of Publication: July 2018.en
dc.identifier.issn0025-729Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/37206en
dc.description.abstract* Asthma care has increasingly focused on personalised management for severe asthma, and recognition of the role and importance of comorbid conditions has increased. * Severe asthma can be crippling; associated comorbid conditions often play a key role in the significant disease morbidity and frequently contribute to a severe and difficult-to-treat asthma phenotype. * Comorbid conditions can be broadly grouped as being either airway-related or airway-unrelated. * Airway-related comorbid conditions with the greatest impact are allergic rhinitis, chronic rhinosinusitis, vocal cord dysfunction, lung fungal sensitisation and underlying structural lung disease. * The most important airway-unrelated comorbid conditions are obesity, obstructive sleep apnoea, gastro-oesophageal reflux disease and anxiety and depression. * A diagnostic and management algorithm for comorbid conditions in severe asthma is outlined. It concentrates initially on the group with common comorbid conditions that can be managed in primary care. If asthma remains troublesome, emphasis can shift to identifying uncommon and more complex factors. The algorithm allows for personalised diagnostic and management pathways to be implemented. * Personalised diagnosis and management of comorbid conditions are essential to achieving effective and improved outcomes for patients with severe asthma.Copyright © 2018, John Wiley and Sons Inc.. All rights reserved.en
dc.languageenen
dc.languageEnglishen
dc.publisherJohn Wiley and Sons Inc. (P.O.Box 18667, Newark NJ 07191-8667, United States)en
dc.relation.ispartofMedical Journal of Australiaen
dc.titleManaging comorbid conditions in severe asthma.en
dc.typeArticleen
dc.type.studyortrialSystematic review and/or meta-analysis-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.5694/mja18.00196en
dc.publisher.placeAustraliaen
dc.identifier.pubmedid30453867 [http://www.ncbi.nlm.nih.gov/pubmed/?term=30453867]en
dc.identifier.source2002440086en
dc.identifier.institution(Bardin, Rangaswamy, Yo) Monash Lung and Sleep, Monash Hospital and University, Melbourne, VIC, Australiaen
dc.description.addressP.G. Bardin, Monash Lung and Sleep, Monash Hospital and University, Melbourne, VIC, Australia. E-mail: philip.bardin@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2019 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailBardin P.G.; philip.bardin@monash.eduen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

50
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.